Is Stem Cell Therapy in Colombia Safe? What to Know

Bottom line up front: Stem cell therapy, when administered by qualified physicians using properly sourced and processed cells, has an established safety profile. The risks are real but manageable — and they are largely the same whether you receive treatment in Colombia or the US. The key to safety is not geography. It is clinic selection.

The Safety Profile of MSC Therapy

Mesenchymal stem cells (MSCs) — the type used in virtually all Colombian stem cell clinics — have been studied extensively. A 2022 systematic review in Stem Cell Research & Therapy analysing over 60 clinical trials found that MSC therapy has a favourable safety profile, with adverse events predominantly limited to mild, self-resolving reactions: temporary soreness at the injection site, mild fever, headache, and fatigue.

Serious adverse events are rare. The most discussed theoretical risk is tumour formation — but MSCs, unlike embryonic stem cells, have not demonstrated tumorigenic potential in clinical use. No confirmed cases of MSC-related tumour formation have been reported in the published literature.

Where the Real Risks Lie

The genuine risks of stem cell therapy are not about the cells themselves. They are about the system around them:

• Unqualified providers: The biggest risk is receiving treatment from someone who is not a licensed, trained physician. This applies in every country.
• Unregulated cell products: Cells that have not been properly screened for infectious disease, tested for viability, or processed under controlled conditions pose real risks.
• Overpromising: Clinics that claim stem cells can cure cancer, reverse ageing, or treat any condition are not practising evidence-based medicine. Overpromising leads to patients making poor decisions based on false expectations.
• Infection risk: As with any injection, there is a small risk of infection at the treatment site. Sterile technique in an accredited facility minimises this.

Colombia's Regulatory Environment

Colombia regulates stem cell therapy through INVIMA (the Colombian equivalent of the FDA) and the Ministry of Health. Clinics must be registered with REPS and physicians must be licensed through Rethus. However — and this is important to understand — stem cell therapy exists in a regulatory grey area in Colombia, as it does in the US. It is neither explicitly prohibited nor fully regulated as an approved pharmaceutical product.

This means the burden of quality assurance falls partly on the clinic and partly on the patient. Choosing a clinic that operates transparently, sources cells from accredited tissue banks, employs qualified physicians, and operates in registered facilities is your most important safety decision.

Read more: What Is Stem Cell Therapy? | Evaluating Clinics | Cost Guide